Condition
Cancer of the Gastrointestinal Tract
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Terminated2
Unknown2
Clinical Trials (4)
Showing 4 of 4 trials
NCT06199115Not ApplicableUnknownPrimary
Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation
NCT04709445Not ApplicableUnknown
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
NCT03628079Phase 1TerminatedPrimary
A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin.
NCT01374100Not ApplicableTerminated
Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy
Showing all 4 trials